Your browser doesn't support javascript.
loading
Prognostic value of the 8th edition American Joint Commission Cancer nodal staging system for patients with head and neck cutaneous squamous cell carcinoma: A multi-institutional study.
Luk, Peter P; Ebrahimi, Ardalan; Veness, Michael J; McDowell, Lachlan; Magarey, Matthew; Gao, Kan; Palme, Carsten E; Clark, Jonathan R; Gupta, Ruta.
Afiliação
  • Luk PP; Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, NSW Health Pathology, Sydney, New South Wales, Australia.
  • Ebrahimi A; Medical School, College of Health and Medicine, Australian National University, Canberra, Australian Capital Territory, Australia.
  • Veness MJ; Department of Head and Neck Surgery, The Canberra Hospital, Canberra, Australian Capital Territory, Australia.
  • McDowell L; Department of Radiation Oncology, Westmead Hospital, Sydney, New South Wales, Australia.
  • Magarey M; Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Gao K; Department of Surgical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Palme CE; The Sydney Head and Neck Cancer Institute, Chris O'Brien Lifehouse, Sydney, New South Wales, Australia.
  • Clark JR; The Sydney Head and Neck Cancer Institute, Chris O'Brien Lifehouse, Sydney, New South Wales, Australia.
  • Gupta R; The Sydney Head and Neck Cancer Institute, Chris O'Brien Lifehouse, Sydney, New South Wales, Australia.
Head Neck ; 43(2): 558-567, 2021 02.
Article em En | MEDLINE | ID: mdl-33118253
ABSTRACT

BACKGROUND:

The 8th edition American Joint Committee on Cancer staging manual (AJCC8) introduced a separate staging system for head and neck cutaneous squamous cell carcinoma (HNcSCC) which parallels mucosal SCC and incorporates extranodal extension (ENE). This study aims to evaluate its prognostic utility.

METHODS:

Univariate analysis of 1146 patients with metastatic HNcSCC from four Australian cancer centers was performed according to both AJCC 7th (AJCC7) and the 8th editions.

RESULTS:

AJCC8 increased classification of 924 (80.6%) patients to either pN2a or pN3b and 341 patients (29.8%) from stage III to IV compared to AJCC7. The disease-specific survival (DSS) was not significantly different between pN1, pN2 or pN3a categories per AJCC8. Estimates of model performance for the AJCC8 pN staging revealed modest predictive capacity (Harrell's C of 0.62 for DSS).

CONCLUSIONS:

The risk stratification according to pN classification of AJCC8 staging system performed poorly as a prognostic indicator.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Carcinoma de Células Escamosas / Neoplasias de Cabeça e Pescoço Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans País como assunto: America do norte / Oceania Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Carcinoma de Células Escamosas / Neoplasias de Cabeça e Pescoço Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans País como assunto: America do norte / Oceania Idioma: En Ano de publicação: 2021 Tipo de documento: Article